• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《临床药理学与治疗学》:未来五年

Clinical Pharmacology & Therapeutics: the next five years.

作者信息

Waldman S A, Terzic A

机构信息

Delaware Valley Institute for Clinical and Translational Science, Department of Pharmacology and Experimental Therapeutics, Division of Clinical Pharmacology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

出版信息

Clin Pharmacol Ther. 2015 Jan;97(1):2-6. doi: 10.1002/cpt.22. Epub 2014 Dec 5.

DOI:10.1002/cpt.22
PMID:25670374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5538564/
Abstract

It has been nearly ten years since we joined the editorial organization of Clinical Pharmacology & Therapeutics (CPT), as part of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) family. During that tenure, the primary mandate has been the growth of CPT, recognized as one of the key voices of the discipline and the Society. Set goals were realized in concert with a strong editorial team, a diverse editorial board, a dedicated editorial staff, and outstanding authors, leveraging a leading publishing infrastructure and responding to the needs of a global readership, expanding membership, and the discipline as a whole. The impending decade anniversary, and the transition to a new publisher, offers a natural juncture to reflect on progress, and chart plans for the future of the Journal.

摘要

我们加入《临床药理学与治疗学》(CPT)编辑组织,成为美国临床药理学与治疗学学会(ASCPT)大家庭的一员,至今已近十年。在那段任期内,主要任务是推动CPT的发展,它被公认为该学科及学会的关键声音之一。既定目标的实现得益于一支强大的编辑团队、多元化的编辑委员会、敬业的编辑人员以及杰出的作者,借助领先的出版基础设施,并回应全球读者的需求、扩大会员规模以及推动整个学科的发展。即将到来的十周年纪念以及向新出版商的过渡,为反思进展以及规划该期刊的未来提供了一个自然契机。

相似文献

1
Clinical Pharmacology & Therapeutics: the next five years.《临床药理学与治疗学》:未来五年
Clin Pharmacol Ther. 2015 Jan;97(1):2-6. doi: 10.1002/cpt.22. Epub 2014 Dec 5.
2
Advancing pharmacometrics and systems pharmacology.推进药物计量学和系统药理学。
Clin Pharmacol Ther. 2012 Nov;92(5):535-7. doi: 10.1038/clpt.2012.151.
3
A Learned Society's Perspective on Publishing.一个学术团体对出版的看法。
J Neurochem. 2016 Oct;139 Suppl 2:17-23. doi: 10.1111/jnc.13674. Epub 2016 Aug 17.
4
Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics.同行评审认证临床药理学与治疗学的质量和创新性。
Clin Pharmacol Ther. 2017 Sep;102(3):373-377. doi: 10.1002/cpt.763.
5
A journal for our challenging, changing times: an editorial vision for the next five years of the Journal of Clinical Psychology.一个适合我们充满挑战和变化的时代的期刊:《临床心理学杂志》未来五年的编辑愿景。
J Clin Psychol. 2011 Sep;67(9):843-9. doi: 10.1002/jclp.20834. Epub 2011 Jul 28.
6
A new cover, a new editorial board.新封面,新编辑委员会。
J Am Acad Dermatol. 2018 Jul;79(1):33. doi: 10.1016/j.jaad.2017.09.007.
7
The silver anniversary of the American Journal of Neuroradiology: twenty-five years of documenting advances in neuroradiology.《美国神经放射学杂志》创刊二十五周年:记录神经放射学进展的二十五年。
AJNR Am J Neuroradiol. 2005 Jan;26(1):1-2.
8
The American Journal of Ophthalmology Will Publish American Ophthalmological Society Theses.《美国眼科杂志》将发表美国眼科学会论文。
Am J Ophthalmol. 2018 Jun;190:xiii-xv. doi: 10.1016/j.ajo.2018.03.019. Epub 2018 Apr 11.
9
Ten years of JACR--a personal history, part I: the run-up to a new journal.《美国放射学会杂志》十年——个人经历,第一部分:新期刊的筹备
J Am Coll Radiol. 2013 Feb;10(2):75-6. doi: 10.1016/j.jacr.2012.09.028. Epub 2012 Dec 14.
10
Hämostaseologie--Progress in Haemostasis. GTH is moving to a European scientific society.止血学——止血领域的进展。德国血栓与止血学会(GTH)正在向一个欧洲科学学会转型。
Hamostaseologie. 2016;36(1):5-6.

引用本文的文献

1
Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics.同行评审认证临床药理学与治疗学的质量和创新性。
Clin Pharmacol Ther. 2017 Sep;102(3):373-377. doi: 10.1002/cpt.763.
2
Clinical Pharmacology & Therapeutics: Past, Present, and Future.临床药理学与治疗学:过去、现在与未来。
Clin Pharmacol Ther. 2017 Mar;101(3):300-303. doi: 10.1002/cpt.592.
3
Developing and Using Therapeutics for Emerging Infections.开发和使用针对新发感染的治疗方法。
Clin Pharmacol Ther. 2015 Oct;98(4):346-51. doi: 10.1002/cpt.183.

本文引用的文献

1
Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.可溶性鸟苷酸环化酶:肺动脉高压和慢性血栓栓塞性肺动脉高压的新治疗靶点。
Clin Pharmacol Ther. 2015 Jan;97(1):88-102. doi: 10.1002/cpt.10. Epub 2014 Nov 28.
2
Advances, nuances, and potential pitfalls when exploiting the therapeutic potential of RNA interference.利用RNA干扰治疗潜力时的进展、细微差别及潜在陷阱
Clin Pharmacol Ther. 2015 Jan;97(1):79-87. doi: 10.1002/cpt.8.
3
Helicase-primase as a target of new therapies for herpes simplex virus infections.解旋酶-引发酶作为单纯疱疹病毒感染新疗法的靶点。
Clin Pharmacol Ther. 2015 Jan;97(1):66-78. doi: 10.1002/cpt.3. Epub 2014 Nov 18.
4
Anti-interleukin therapy in asthma.哮喘中的抗白细胞介素疗法。
Clin Pharmacol Ther. 2015 Jan;97(1):55-65. doi: 10.1002/cpt.11. Epub 2014 Dec 15.
5
Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.通过定量转化和临床药理学优化肿瘤治疗:挑战与机遇
Clin Pharmacol Ther. 2015 Jan;97(1):37-54. doi: 10.1002/cpt.7. Epub 2014 Dec 9.
6
FDA designations for therapeutics and their impact on drug development and regulatory review outcomes.美国食品药品监督管理局对治疗药物的认定及其对药物研发和监管审评结果的影响。
Clin Pharmacol Ther. 2015 Jan;97(1):29-36. doi: 10.1002/cpt.1. Epub 2014 Dec 1.
7
Targeting leukocyte trafficking for the treatment of inflammatory bowel disease.靶向白细胞运输以治疗炎症性肠病。
Clin Pharmacol Ther. 2015 Jan;97(1):22-8. doi: 10.1002/cpt.6. Epub 2014 Dec 2.